List of approved countries
Updated 22 December 2021
Is this page useful?
Guidance
List of approved countries for authorised human medicines
Approved countries for batch testing and importation of medicines
Documents
Details
The Human Medicines Regulations 2012 refers to lists of approved countries for:
- Importation of medicines under a wholesale dealer’s licence
- Batch testing of medicines
- Manufacturing of active substances with regulatory standards equivalent to the UK
The list of approved countries will enable UK importers and wholesalers to continue to recognise QP certification and regulatory standards for active substance manufacture performed in certain countries in the same way as before 1 January 2021. The UK’s acceptance of batch testing done in EEA countries will be reviewed before 31 December 2022. A two-year notice period will be given in the case of changes.
This guidance provides the lists of countries and a summary of the circumstances under which the lists can be used.
Contact
For further information, please email our Customer Services Centre at info@mhra.gov.uk or call 020 3080 6000. Alternatively, contact your Trade Association by emailing:
- Association of the British Pharmaceutical Industry (ABPI): regulatory@abpi.org.uk
- British Generic Manufacturers Association (BGMA): info@britishgenerics.co.uk
- BioIndustry Association (BIA): regulatory@bioindustry.org
- Clinical & Contract Research Association (CCRA): mail@ccra.org.uk
- Ethical Medicines Industry Group (EMIG): info@emig.org.uk
- Health Food Manufacturers’ Association (HFMA): pennyviner@btconnect.com
- The National Pharmacy Association (NPA): independentsvoice@npa.co.uk
- Proprietary Association of Great Britain (PAGB): regulatory@pagb.co.uk
Guidance
List of approved countries from 1 January 2021
Updated 25 September 2020
New rules for January 2021
The UK has left the EU, and the transition period after Brexit comes to an end this year.
This page tells you what you’ll need to do from 1 January 2021. It will be updated if anything changes.
For current information, read: Good manufacturing practice and good distribution practice
You can also read about the transition period.
